MVIR:STO
Medivir AB
1,49 SEK
arrow_downward
-0,27%(-0,0040) 1 d.
12. 10., 12:46:47 GMT+2 · SEK
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre MVIR…
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
932,52 mil.
Priem. obj.
1,45 mil.
Objem
692,57 tis.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
932,52 mil.
Priem. obj.
1,45 mil.
Objem
692,57 tis.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 16 minútami
Immersion CEO, President & Chairperson Acquires 2.3% More Stock
marketscreener.com
·
pred 36 minútami
Goldman Sachs Adjusts Price Target on Dow to $31 From $33
Yahoo Finance
·
pred 46 minútami
2 S&P 500 Stocks to Own for Decades and 1 We Ignore
Stocktwits
·
pred 4 hodinami
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Informácie o subjekte Medivir AB